- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01701414
Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures (FNB)
Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures: a Randomized Controlled Clinical Study
The purpose of this study is to determine if ultrasound guided femoral nerve blocks (localized anesthesia in the upper thigh) provide effective pain relief in adult patients with hip fractures in the emergency department and to determine if femoral nerve blocks can then be used to reduce the use of injected analgesia (anesthesia), therefore also causing fewer adverse effects associated with injected analgesia (such as bruising at the site of injection).
100 patients with hip fractures will be enrolled in the study. Patients will be randomly assigned to receive a femoral nerve block (FNB) plus injected analgesia or standard care (SC), which is injected analgesia alone.
Using guidance from an ultrasound machine, the FNB group will have 20ml of 0.5% bupivacaine (a local anesthetic of long duration) injected into the front of the thigh, at the site of pain. Patients randomized to the SC group will receive an injection of saline (saltwater) so that no neither the patient or the treating physician knows to which group the patient was randomized. All blocks will be performed in the emergency department by an emergency physician trained in the use of ultrasound and ultrasound guided nerve blocks.
Subjects will be asked to rate their pain on a numeric pain scale both before and after intervention (30 min, 60 min, 12 hrs and 24 hrs after injection, as long as the patient is in the ER still). Additional data to be collected includes demographics, vital signs, and course of treatment resulting from the ED visit.
Hypothesis: US-guided femoral nerve blocks can provide effective pain control and possibly decrease or eliminate the need for narcotics.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hip fractures are a significant cause of morbidity and mortality in the elderly. In the acute setting, safe and effective pain control is of the utmost importance. At present, this is typically achieved with the use of parenteral opioids. However in older individuals, who often have other medical comorbidities, the use of narcotics for pain control must be balanced with their potentially deleterious consequences: namely respiratory depression, hypotension, and mental confusion. Both poor pain control and the use of opioid medications have been associated with acute confusional states in the elderly. 1,2 Regional anesthesia can possibly provide adjunctive or even alternative pain control that is both safe and effective.Femoral nerve blocks, using local anesthetics, have been described as a method to reduce pain and the requirement for systemic analgesia, specifically opioids. Prior research has demonstrated feasibility and effective pain control of the femoral nerve block in the ED setting. Bedside ultrasound (US) can be used to precisely visualize the femoral neurovascular anatomy when performing a femoral nerve block and has distinct advantages when performing this procedure in the ED setting.
Study Objectives The primary aim of this study is to determine the relative effectiveness of ultrasound guided femoral nerve blocks in older adult patients with hip fractures in the emergency department as compared with parenteral narcotics alone. A secondary aim of this study is to determine if femoral nerve blocks reduce both the use of parenteral narcotics and the incidence adverse effects associated with parenteral analgesia (delirium, hypotension, respiratory depression) in hip fracture patients both in the emergency department and during their hospital stay.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English speaking
- Adults over age 55
- Able to understand and give informed consent
- Comfortable with the experimental protocol as outlined to them by the RA or physician investigator
- Have radiologically confirmed hip fractures: femoral head, femoral neck intertrochanteric, or subtrochanteric femur fractures
Exclusion Criteria:
- Femoral artery grafts on the same side as the fracture
- Extensive lower extremity trauma
- Concurrent tibia-fibula fractures
- Hypersensitivity to local anesthetics or morphine
- Neurovascular injury
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Standard Care (SC)
The SC group will receive a sham injection of normal saline in order to blind both the participants and the treating physicians.
A 7.5-MHz linear transducer will be placed on the side of the affected hip 1cm below the inguinal ligament.
1cm lateral to the ultrasound probe, a 27 gauge needle and syringe will be used to inject 3cc of 0.9% subcutaneously.
The SC group will then be cared for by the Emergency Department physicians according to their regular clinical practice.
|
1cm lateral to the ultrasound probe, a 27 gauge needle and syringe will be used to inject 3cc of 0.9% NS subcutaneously.
The SC group will then be cared for by the Emergency Department physicians according to their regular clinical practice
|
Experimental: Femoral Nerve Block (FNB)
Participants randomized to the second group, FNB group, will receive an Ultrasound (US) guided femoral nerve block using a Sonosite TitanTM (Sonosite, Inc., Bothell, WA) with a 7.5-MHz linear array transducer.
Using this technique, 25ml of 0.5% bupivacaine will be injected along the nerve sheath.
The femoral, obturator, and lateral cutaneous nerve are anesthetized with this technique (thus the name "3-in-1 femoral block" is often used), providing maximum analgesia to the hip.
|
25ml of 0.5% bupivacaine will be injected along the nerve sheath.
The nerve block will be administered by one of the physician co- investigators all of whom are emergency physicians and all of whom have been trained in the use of ultrasound and ultrasound guided nerve blocks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Reporting at Least One NRS Rating
Time Frame: 30 minutes after the block is administered then every 60 minutes until discharge. Desired outcome was a low NRS rating.
|
Participants report their discomfort using a Numerical Rating Scale (NRS).
Pain level is reported as 0 (lowest-no pain) to 10 (highest level of pain).
Each patient enrolled in the study reported their level of pain at least once during their participation in the study.
|
30 minutes after the block is administered then every 60 minutes until discharge. Desired outcome was a low NRS rating.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Otto Liebmann, MD, Rhode Island Hospital
- Principal Investigator: Francesca Beaudoin, MD, MS, Rhode Island Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 210423
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Smith & Nephew, Inc.Terminated
-
Carilion ClinicCompleted
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
Rabin Medical CenterUnknown
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
University of LeedsCitieffe S.r.lUnknownUnilateral Unstable HipUnited Kingdom
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
Clinical Trials on Placebo: 3cc of 0.9% Normal Saline
-
Vanderbilt University Medical CenterActive, not recruitingPostural Tachycardia SyndromeUnited States
-
Tri-Service General HospitalCompleted
-
University of Texas Southwestern Medical CenterCompletedAcute BronchiolitisUnited States
-
GemVax & KaelCompletedBenign Prostatic Hyperplasia (BPH)Korea, Republic of
-
Ann & Robert H Lurie Children's Hospital of ChicagoWithdrawn
-
Mayo ClinicWithdrawnHeart Failure | Left Ventricular Assist Device | Natriuretic Peptide
-
BioAegis Therapeutics Inc.CompletedCommunity-acquired PneumoniaAustralia, Georgia
-
University of HaifaWestern Galilee Hospital-NahariyaRecruiting
-
Virginia Commonwealth UniversityUnited States Department of DefenseWithdrawn
-
PhytoHealth CorporationRecruitingCancer-related FatigueTaiwan